ThinkCyte advanced its AI-driven cell analysis strategy this week, centering activity on its VisionSort morphology-based sorting platform. The company used multiple webinars and academic collaborations to highlight VisionSort’s ability to uncover hidden cell phenotypes and refine morphology-based critical quality attributes for drug discovery and cell therapy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
A key upcoming webinar, “Unlock Hidden Cell Phenotypes,” will feature Dr. Jeanne Rivera of the U.K. National Measurement Laboratory at LGC, focusing on cell measurement metrology and morphology-based CQAs. By aligning with a national metrology lab, ThinkCyte is seeking to validate VisionSort in regulated, measurement-intensive environments relevant to bioprocessing and analytical development.
The company also reported growing engagement at Scripps Research, where VisionSort is being demonstrated to experts in flow cytometry, regenerative medicine, drug discovery, and AI in biology. Onsite demos throughout April, along with a Scripps-hosted webinar featuring Dr. Romain Ballet and live VisionSort demonstrations, are intended to showcase label-free capabilities such as lineage tracing and disease-associated morphotype detection.
In addition, ThinkCyte announced adoption of VisionSort by Kyoto University’s Center for iPS Cell Research and Application, or CiRA, a prominent player in the global iPSC community. CiRA plans to deploy VisionSort’s high-speed imaging and AI-based sorting in regenerative medicine and cell therapy research, adding an influential academic reference site for the platform.
Collectively, these initiatives strengthen ThinkCyte’s visibility and credibility as a next-generation alternative to traditional flow cytometry. While financial impact will depend on converting pilots into broader deployments, the week’s activities point to constructive momentum for VisionSort through increased academic validation, targeted customer engagement, and deeper integration into advanced cell analytics workflows.